Comparison of analytical performances between clot waveform analysis and FibWave in edoxaban-treated patients and healthy controls.

activated partial thromboplastin time anticoagulants clot waveform analysis edoxaban fibrin fibrinolysis prothrombin time

Journal

Research and practice in thrombosis and haemostasis
ISSN: 2475-0379
Titre abrégé: Res Pract Thromb Haemost
Pays: United States
ID NLM: 101703775

Informations de publication

Date de publication:
Oct 2022
Historique:
received: 01 04 2022
revised: 10 08 2022
accepted: 18 08 2022
entrez: 9 11 2022
pubmed: 10 11 2022
medline: 10 11 2022
Statut: epublish

Résumé

The activated partial thromboplastin time (aPTT) and the prothrombin time (PT) are widely available coagulation parameters which are however poor predictors of the anticoagulant effect of direct oral anticoagulants (DOACs). Some coagulometers use the clot waveform analysis (CWA) to assess the clotting time but mainly based on a unique parameter. The improvement of these methodologies and the evaluation of the other waveform parameters may increase the sensitivity to DOACs. To assess the performance of an improved clot waveform an method (i.e. FibWave) to detect the impact of edoxaban on the coagulation and the fibrinolytic systems. Seventy-one samples from patients treated with edoxaban collected at minimum concentration (C PT and FibEx clotting time were strongly correlated to edoxaban concentration (Pearson FibEx is more sensitive than aPTT- and PT-based CWA for the detection of the clinically relevant anticoagulant level of edoxaban.

Identifiants

pubmed: 36349263
doi: 10.1002/rth2.12804
pii: S2475-0379(22)02443-8
pmc: PMC9634266
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e12804

Informations de copyright

© 2022 The Authors. Research and Practice in Thrombosis and Haemostasis published by Wiley Periodicals LLC on behalf of International Society on Thrombosis and Haemostasis (ISTH).

Références

Thromb Res. 2020 Sep;193:146-153
pubmed: 32559572
Thromb Haemost. 2016 Jan;115(2):368-81
pubmed: 26510969
Chest. 2016 Feb;149(2):315-352
pubmed: 26867832
Thromb Res. 2017 Sep;157:29-37
pubmed: 28686914
Sci Rep. 2021 Jan 19;11(1):1793
pubmed: 33469056
Int J Lab Hematol. 2021 Feb;43(1):e48-e51
pubmed: 33037773
Clin Appl Thromb Hemost. 2020 Jan-Dec;26:1076029620912027
pubmed: 32862666
J Thromb Haemost. 2019 Aug;17(8):1273-1287
pubmed: 31063645
Int J Lab Hematol. 2019 Jun;41(3):316-324
pubmed: 30730600
Int J Lab Hematol. 2020 Jun;42(3):292-298
pubmed: 32078255
Int J Lab Hematol. 2017 Aug;39(4):402-408
pubmed: 28304137
Int J Lab Hematol. 2019 May;41 Suppl 1:33-39
pubmed: 31069969
Thromb Res. 2019 Dec;184:8-15
pubmed: 31677449
Int J Lab Hematol. 2021 Aug;43(4):802-812
pubmed: 33314736
Thromb Haemost. 1997 Sep;78(3):1079-87
pubmed: 9308757
Thromb Res. 2018 Nov;171:160-166
pubmed: 30316961
Arch Cardiovasc Dis. 2013 Jun-Jul;106(6-7):382-93
pubmed: 23810130
Thromb Haemost. 2022 Oct;122(10):1723-1731
pubmed: 35785816
Int J Lab Hematol. 2021 Apr;43(2):273-280
pubmed: 32964648
J Thromb Haemost. 2018 Nov;16(11):2276-2288
pubmed: 30176116
Thromb Haemost. 2015 Jan;113(1):154-64
pubmed: 25231101
J Clin Pathol. 2021 Apr;74(4):251-256
pubmed: 32796051
Europace. 2021 Oct 9;23(10):1612-1676
pubmed: 33895845
Thromb Haemost. 2018 Mar;118(3):437-450
pubmed: 29433148
Int J Lab Hematol. 2022 Apr;44(2):e79-e83
pubmed: 34613661
Thromb J. 2014 Nov 04;12:24
pubmed: 25750588
Clin Appl Thromb Hemost. 2021 Jan-Dec;27:10760296211012094
pubmed: 34027710
Thromb Res. 2013 Mar;131(3):e100-9
pubmed: 23313382
Int J Lab Hematol. 2020 Aug;42(4):411-417
pubmed: 32297466
Semin Thromb Hemost. 2017 Apr;43(3):277-290
pubmed: 28249326
Thromb J. 2015 Jan 12;13:1
pubmed: 25937820
Thromb Res. 2020 Jul;191:78-81
pubmed: 32402997
Int J Lab Hematol. 2021 Feb;43(1):7-20
pubmed: 32946681
Br J Haematol. 2019 Nov;187(4):518-529
pubmed: 31335970
Thromb Haemost. 2013 Oct;110(4):723-31
pubmed: 23846172
Int J Lab Hematol. 2021 Dec;43(6):1539-1548
pubmed: 34097808
Thromb Haemost. 2021 Aug;121(8):1008-1020
pubmed: 33742436
Hamostaseologie. 2017 Jul 05;37(4):
pubmed: 28678302
J Thromb Thrombolysis. 2019 Jul;48(1):103-110
pubmed: 30972711
Pathology. 2016 Dec;48(7):712-719
pubmed: 27780603
Thromb Haemost. 2013 Sep;110(3):543-9
pubmed: 23783171
Thromb J. 2019 Jun 28;17:12
pubmed: 31297038
Res Pract Thromb Haemost. 2020 Apr 23;4(4):619-627
pubmed: 32548561
J Thromb Haemost. 2018 Feb;16(2):209-219
pubmed: 29193737
Int J Lab Hematol. 2022 Jun;44(3):610-618
pubmed: 35029031
Clin Exp Med. 2018 Aug;18(3):325-336
pubmed: 29417256
Int J Lab Hematol. 2017 Dec;39(6):561-568
pubmed: 28876509
J Thromb Haemost. 2016 Nov;14(11):2194-2201
pubmed: 27566988

Auteurs

Jonathan Evrard (J)

Department of Pharmacy Université de Namur, Namur Thrombosis and Hemostasis Center (NTHC), Namur Research Institute for Life Sciences (NARILIS) Namur Belgium.

Romain Siriez (R)

Department of Pharmacy Université de Namur, Namur Thrombosis and Hemostasis Center (NTHC), Namur Research Institute for Life Sciences (NARILIS) Namur Belgium.

Céline Bouvy (C)

Qualiblood s.a. Namur Belgium.

Julien Favresse (J)

Department of Pharmacy Université de Namur, Namur Thrombosis and Hemostasis Center (NTHC), Namur Research Institute for Life Sciences (NARILIS) Namur Belgium.
Department of Laboratory Medicine Clinique Saint-Luc Bouge Namur Belgium.

Halil Yildiz (H)

Department of Internal Medicine and Infectious Diseases, Cliniques Universitaires Saint-Luc Université Catholique de Louvain Brussels Belgium.

Philippe Hainaut (P)

Department of Internal Medicine and Infectious Diseases, Cliniques Universitaires Saint-Luc Université Catholique de Louvain Brussels Belgium.

François Mullier (F)

Hematology Laboratory Université Catholique de Louvain, CHU UCL Namur, Namur Thrombosis and Hemostasis Center (NTHC), Namur Research Institute for Life Sciences (NARILIS) Yvoir Belgium.

Jean-Michel Dogné (JM)

Department of Pharmacy Université de Namur, Namur Thrombosis and Hemostasis Center (NTHC), Namur Research Institute for Life Sciences (NARILIS) Namur Belgium.

Jonathan Douxfils (J)

Department of Pharmacy Université de Namur, Namur Thrombosis and Hemostasis Center (NTHC), Namur Research Institute for Life Sciences (NARILIS) Namur Belgium.
Qualiblood s.a. Namur Belgium.

Classifications MeSH